Amalgamated Bank Pacific Biosciences Of California, Inc. Transaction History

Amalgamated Bank

$13.6 Billion
Q3 2025

A detailed history of Amalgamated Bank transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 9,441 shares of PACB stock, worth $17,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,441

Previous 9,441 -0.0%

Holding current value

$17,560

Previous $11,000 9.09%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$1.14 - $2.1 $1,382 - $2,547	1,213 Added 14.74%	9,441 $11,000
Q1 2024 Apr 23, 2024	SELL	$3.52 - $9.59 $73,905 - $201,351	-20,996 Reduced 71.85%	8,228 $31,000
Q4 2023 Feb 06, 2024	SELL	$5.97 - $10.36 $14,620 - $25,371	-2,449 Reduced 7.73%	29,224 $287,000
Q2 2023 Aug 11, 2023	BUY	$9.97 - $14.05 $65,024 - $91,634	6,522 Added 25.93%	31,673 $421,000
Q1 2023 May 02, 2023	SELL	$7.94 - $12.02 $38,064 - $57,623	-4,794 Reduced 16.01%	25,151 $291,000
Q4 2022 Feb 10, 2023	BUY	$5.67 - $11.2 $5,993 - $11,838	1,057 Added 3.66%	29,945 $245,000
Q3 2022 Nov 09, 2022	BUY	$3.93 - $8.57 $1,104 - $2,408	281 Added 0.98%	28,888 $168,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $5,523 - $14,330	1,374 Added 5.05%	28,607 $126,000
Q1 2022 Jun 30, 2022	SELL	$8.43 - $20.9 $17,669 - $43,806	-2,096 Reduced 7.15%	27,233 $248,000
Q4 2021 Feb 15, 2022	SELL	$19.26 - $30.08 $5,604 - $8,753	-291 Reduced 0.98%	29,329 $600,000
Q3 2021 Oct 29, 2021	SELL	$24.86 - $35.02 $49,595 - $69,864	-1,995 Reduced 6.31%	29,620 $757,000
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $157,148 - $253,832	7,047 Added 28.68%	31,615 $1.11 Million
Q1 2021 May 13, 2021	SELL	$26.38 - $51.15 $38,778 - $75,190	-1,470 Reduced 5.65%	24,568 $818,000
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $17,997 - $48,849	1,714 Added 7.05%	26,038 $675,000
Q3 2020 Oct 30, 2020	BUY	$3.61 - $9.87 $8,960 - $24,497	2,482 Added 11.36%	24,324 $240,000
Q2 2020 Aug 10, 2020	SELL	$2.65 - $4.03 $8,970 - $13,641	-3,385 Reduced 13.42%	21,842 $75,000
Q1 2020 May 13, 2020	SELL	$2.36 - $5.26 $1,281 - $2,856	-543 Reduced 2.11%	25,227 $77,000
Q4 2019 Feb 13, 2020	BUY	$4.6 - $5.57 $3,712 - $4,494	807 Added 3.23%	25,770 $132,000
Q3 2019 Nov 13, 2019	SELL	$4.99 - $6.16 $773 - $954	-155 Reduced 0.62%	24,963 $129,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $26,894 - $33,663	4,543 Added 22.08%	25,118 $152,000
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $4,875 - $5,305	717 Added 3.61%	20,575 $149,000
Q4 2018 Feb 15, 2019	BUY	$3.99 - $7.82 $79,233 - $155,289	19,858 New	19,858 $147,000
Q3 2018 Nov 14, 2018	SELL	$3.52 - $5.55 $65,957 - $103,995	-18,738 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$2.11 - $3.92 $6,372 - $11,838	3,020 Added 19.21%	18,738 $67,000
Q1 2018 May 22, 2018	BUY	$2.05 - $3.23 $3,208 - $5,054	1,565 Added 11.06%	15,718 $32,000
Q4 2017 Feb 13, 2018	BUY	$2.59 - $5.44 $2,665 - $5,597	1,029 Added 7.84%	14,153 $37,000
Q3 2017 Nov 09, 2017	BUY	$3.2 - $5.57 $41,996 - $73,100	13,124	13,124 $69,000

Others Institutions Holding PACB

# of Institutions

241

Shares Held

194M

Call Options Held

879K

Put Options Held

847K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $418M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Pacific Biosciences Of California, Inc. Transaction History